About Diamond Drugs
Diamond Drugs is a Healthcare company based in Kolkata (India) founded in 1954. It provides pharmaceutical contract manufacturing, medicine sales, and formulations in India. It operates on a B2B model. The company has 84 employees. Its website diamonddrugs.co.in draws about 11 thousand monthly visits. Its Indian entity Diamond Drugs Private Limited reported revenue of ₹38.26 Cr. Diamond Drugs offers products and services including Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit. Its focus areas include Pharmaceuticals, Manufacturing, Contract Manufacturing and OTC Products.
Company details
Diamond Drugs, a Kolkata-based company, has been involved in pharmaceutical contract manufacturing and marketing for over six decades. It produces and supplies formulations, including OTC products, while adhering to ISO and cGMP standards. The company serves clients in Indias Eastern Zone, focuses on quality production, and explores new markets like Andaman and Nicobar Islands. It also engages in third-party manufacturing and product innovation.
- Headquarters Kolkata, India
- Employees 84
- SectorsHealthcare
- Email••••••••
- Website diamonddrugs.co.in
- Social Facebook Instagram
- Legal Name Diamond Drugs Private Limited
- Date of Incorporation 15 Dec, 2004
- Jurisdiction Kolkata, West Bengal, India
- Annual Revenue₹38.26 Cr
FY 2024 · +2% YoY
- Net Profit₹5.84 Cr
FY 2024 · 15% margin
- EBITDA₹8.16 Cr
FY 2024 · 21% margin
- Employee Count84
Associated legal entities of Diamond Drugs
Diamond Drugs operates through Diamond Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Diamond Drugs Private Limited CIN U24239WB2004PTC100709 | Active | 15 Dec 2004 | Kolkata, West Bengal | ₹38.3 Cr | 84 | 3 | View details |
Products & Services of Diamond Drugs
Diamond Drugs offers a comprehensive portfolio of products and services, including Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit.
Appetizer syrup widely prescribed for digestive support
Cream for treating second-degree superficial burns
Pharmaceutical product for general medicinal use
Skin gel for soothing and healing purposes
Veterinary formulation for animal health care
Board of directors of Diamond Drugs Private Limited (Diamond Drugs)
Diamond Drugs Private Limited is the primary company behind Diamond Drugs. The board of Diamond Drugs Private Limited currently have 3 directors; the longest-serving is Mihir Sarkar, appointed in 2004. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mihir Sarkar DIN 00684806 | Director | 15 Dec 2004 | 21 yrs 10 mo | Diamond Drugs Private Limited |
| Prabir Kumar Sarkar DIN 01462450 | Director | 15 Dec 2004 | 21 yrs 10 mo | Diamond Drugs Private Limited |
| Soumyajit Sarkar DIN 07132395 | Director | 06 Sep 2024 | 2 yrs 2 mo | Diamond Drugs Private Limited |
Financials of Diamond Drugs
Figures of Diamond Drugs Private Limited, the primary company behind Diamond Drugs, for FY 2024. Revenue was ₹38.26 Cr (+2% year on year). Net profit was ₹5.84 Cr (15% margin). EBITDA was ₹8.16 Cr (21% margin). Revenue has grown at a compounded annual rate of +29% over three years and +15% over five years.
- ₹38.26 CrRevenue · FY 2024 · +2% YoY
- ₹5.84 CrNet profit · 15% margin
- ₹8.16 CrEBITDA · 21% margin
- ₹1.13 CrPaid-up capital
- 84Employees (provident fund records)
- +29%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Diamond Drugs Private Limited are on its company page.
Detailed financial statements for Diamond Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Diamond Drugs
The website of Diamond Drugs (diamonddrugs.co.in) receives about 10.7K visits a month.
- Monthly visits10.7K
▲ 1024.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diamond Drugs
Diamond Drugs was founded in 1954.
Diamond Drugs is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Diamond Drugs has 84 employees.
The primary company behind Diamond Drugs, Diamond Drugs Private Limited, reported revenue of ₹38.26 Cr for FY 2024, up 2% year on year.
Diamond Drugs, a Kolkata-based company, has been involved in pharmaceutical contract manufacturing and marketing for over six decades. It produces and supplies formulations, including OTC products, while adhering to ISO and cGMP standards. The company serves clients in Indias Eastern Zone, focuses on quality production, and explores new markets like Andaman and Nicobar Islands. It also engages in third-party manufacturing and product innovation.
Diamond Drugs offers Apilysin, Lycimond, Livolysin, Lycimond Aloe Vera, and Sovit.
Diamond Drugs operates through Diamond Drugs Private Limited.
The legal entities of Diamond Drugs currently have 3 directors, including Soumyajit Sarkar, Mihir Sarkar, Prabir Kumar Sarkar.